Patterns of care for stage III non–small cell lung cancer in Australia
Open Access
- 14 March 2019
- journal article
- review article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 15 (3) , 93-100
Abstract
Stage III non–small cell lung cancer (NSCLC) makes up a third of all NSCLC cases and is potentially curable. Despite this 5‐year survival rates remain between 15% and 20% with chemoradiation treatment alone given with curative intent. With the recent exciting breakthroughs in immunotherapy use (durvalumab) for stage III NSCLC, further improvements in patient survival can be expected.Most patients with stage III NSCLC present initially to their general practitioner (GP). The recommended time from GP referral to first specialist appointment is less than 14 days with treatment initiated within 42 days. Our review found that there is a shortfall in meeting these recommendations, however a number of initiatives have been established in Australia to improve timely and accurate diagnosis and treatment patterns. The lung cancer multidisciplinary team (MDT) is critical to consistency of evidence‐based diagnosis and treatment and can improve patient survival. We aimed to review current patterns of care and clinical practice recommendations for stage III NSCLC across Australia and identify opportunities to improve practice in referral, diagnosis and treatment pathways.Keywords
Funding Information
- AstraZeneca Australia
This publication has 44 references indexed in Scilit:
- Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007Thorax, 2013
- Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countriesAnnals of Oncology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- A Multicenter, Prospective, Advanced Diagnostic Bronchoscopy Outcomes RegistryChest, 2010
- Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapyRadiation Oncology, 2010
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancerArchives of Medical Science, 2010
- The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non‐small cell lung cancerInternal Medicine Journal, 2009
- The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literatureRadiotherapy and Oncology, 2008